Laboratory Based Surveillance of HIV-1 Acquired Drug Resistance in Cameroon: Implications for Use of Tenofovir-Lamivudine-Dolutegravir (TLD) as Second- or Third-Line Regimens

Increased HIV drug resistance (HIVDR) with antiretroviral therapy (ART) rollout may jeopardize therapeutic options, especially in this era of transition to fixed-dose tenofovir-lamivudine-dolutegravir (TLD). We studied acquired HIVDR (ADR) patterns and describe potentially active drugs after first-...

Descripción completa

Detalles Bibliográficos
Autores principales: Fokam, Joseph, Chenwi, Collins Ambe, Takou, Desire, Santoro, Maria Mercedes, Tala, Valere, Teto, George, Beloumou, Grace, Semengue, Ezechiel Ngoufack Jagni, Dambaya, Beatrice, Djupsa, Sandrine, Kembou, Etienne, Bouba, Nounouce Pamen, Ajeh, Rogers, Cappelli, Giulia, Mbanya, Dora, Colizzi, Vittorio, Ceccherini-Silberstein, Francesca, Perno, Carlo-Federico, Ndjolo, Alexis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459610/
https://www.ncbi.nlm.nih.gov/pubmed/37632026
http://dx.doi.org/10.3390/v15081683

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10459610/
https://www.ncbi.nlm.nih.gov/pubmed/37632026
http://dx.doi.org/10.3390/v15081683

Ejemplares similares